News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
2022-06-09 1:27:4 pm Cardiol Therapeutics launches up to $50M at-the-market equity offering program SeekingAlpha
Jun-09-22 04:05PM Cardiol Therapeutics Announces At-The-Market Equity Offering Program Newsfile
May-27-22 01:00PM Market Movers. Todays Top Stock Picks For New & Trending Opportunities ACCESSWIRE
May-24-22 07:00AM CEO Presenting on the Emerging Growth Conference on May 25 Register Now GlobeNewswire
May-19-22 07:27AM Cardiol Therapeutics Appoints Teri Loxam and Chris Waddick to its Board of Directors Newsfile
May-17-22 07:27AM Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-Label Pilot Study of CardiolRx(TM) for Recurrent Pericarditis Newsfile
May-02-22 02:42PM We're Not Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn Simply Wall St.
Mar-24-22 07:27AM Cardiol Therapeutics Announces Year-End 2021 Update on Operations Newsfile
Mar-22-22 07:27AM Cardiol Therapeutics to Participate in Cantor Fitzgerald's Virtual Rare Orphan Disease Summit Newsfile
Mar-15-22 07:27AM Cardiol Therapeutics Appoints Jennifer M. Chao to Its Board of Directors Newsfile
Mar-01-22 07:27AM Cardiol Therapeutics Receives Clearance from the FDA and Regulatory Agencies in Brazil and Mexico for Important Protocol Amendments Designed to Expedite Patient Enrollment in the LANCER Trial Newsfile
Feb-02-22 06:30AM When Will Cardiol Therapeutics Inc. (TSE:CRDL) Turn A Profit? Simply Wall St.
Jan-19-22 07:27AM Cardiol Therapeutics Appoints Thought Leaders in Cardiovascular Medicine to its Scientific Advisory Board Newsfile
Nov-05-21 09:18AM Cardiol Therapeutics Announces Closing of US$50 Million Public Offering Newsfile
Nov-04-21 08:52AM What You Need To Know About Cardiol Therapeutics Inc.'s (TSE:CRDL) Investor Composition Simply Wall St.
Nov-03-21 08:36AM Cardiol Therapeutics Announces Pricing of Public Offering of Units CNW Group
Nov-02-21 04:04PM Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Units CNW Group
Oct-25-21 07:27AM Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis Newsfile
Oct-18-21 07:27AM Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx(TM), into Brazil, Mexico, and Canada Newsfile
Sep-16-21 07:27AM Cardiol Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference Newsfile
Sep-10-21 04:33PM Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants Issued on June 4, 2020 Newsfile
Sep-07-21 07:27AM Cardiol Therapeutics Appoints Michael J. Willner to Its Board of Directors Newsfile
Aug-24-21 07:27AM Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis Newsfile
Aug-19-21 06:52AM When Will Cardiol Therapeutics Inc. (TSE:CRDL) Turn A Profit? Simply Wall St.